Targets of protective antibodies to malaria during pregnancy.
Beeson
James G
JG
Walter and Eliza Hall Institute of Medical Research and Department of Medicine, University of Melbourne, Royal Melbourne Hospital, Victoria, Australia. beeson@wehi.edu.au
Rogerson
Stephen J
SJ
Elliott
Salenna R
SR
Duffy
Michael F
MF
D000818:Animals; D000913:Antibodies, Protozoan / Q000276:immunology*; D000940:Antigenic Variation; D000953:Antigens, Protozoan / Q000276:immunology*; D002809:Chondroitin Sulfates / Q000276:immunology; D004912:Erythrocytes / Q000276:immunology / Q000469:parasitology; D005260:Female; D006801:Humans; D008288:Malaria / Q000276:immunology* / Q000517:prevention & control; D010920:Placenta / Q000276:immunology / Q000469:parasitology; D010963:Plasmodium falciparum / Q000276:immunology*; D010966:Plasmodium vivax / Q000276:immunology*; D011247:Pregnancy; D015597:Pregnancy Complications, Parasitic / Q000276:immunology*; D015800:Protozoan Proteins / Q000276:immunology
D000913:Antibodies, Protozoan; D000953:Antigens, Protozoan; D015800:Protozoan Proteins; C085731:erythrocyte membrane protein 1, Plasmodium falciparum; D002809:Chondroitin Sulfates